文献速递临床试验与 GCP真实世界研究与卫生经济

免费分发基本药物2年后的用药依从性:CLEAN Meds随机临床试验

Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial.
PubMed 文献 · PLoS Med · 2021-05-21

该试验将786名因费用问题而未用药的基层患者随机分为免费分发基本药物组和常规获取组,2年后免费组分发组全处方依从率为38.7%,常规组为28.6%,绝对差异10.1%(95%CI 3.3-16.9,P=0.004)。免费分发未显著改善糖尿病、血压和LDL胆固醇等替代结局,但2年总医疗费用中位数更低(差异CAN$1,117,95%CI CAN$445-1,778,P=0.006)。

要点

  • 免费分发基本药物可提高因费用问题而不依从患者的用药依从性。
  • 免费分发未显著改善糖尿病、血压和LDL胆固醇等替代健康结局。
  • 免费分发与2年总医疗费用中位数降低相关。

核心结论

  • 对因费用相关不依从的患者免费分发基本药物大幅提高依从性,未影响替代健康结局,并降低2年总医疗费用。

研究设计与样本

  • 随机对照试验,2016年6月1日至2017年4月28日在加拿大安大略省纳入786名报告因费用而未用药的基层患者,随机分为免费分发基本药物组(n=395)和常规药物获取组(n=391)。

主要发现

  • 2年后全处方依从率免费分发组为38.7%,常规获取组为28.6%,绝对差异10.1%(95%CI 3.3-16.9,P=0.004)。
  • 糖尿病控制(HbA1c差异0.27,95%CI -0.25-0.79,P=0.302)、收缩压(差异-3.9,95%CI -9.9-2.2,P=0.210)和LDL胆固醇(差异0.26,95%CI -0.08-0.60,P=0.130)无统计学显著差异。
  • 2年总医疗费用中位数免费分发组更低(差异CAN$1,117,95%CI CAN$445-1,778,P=0.006)。
  • 免费分发组51例发生严重不良事件,常规获取组68例发生严重不良事件(P=0.091)。

临床怎么用

  • 对于因费用问题而不依从的患者,免费提供基本药物可作为一种提高依从性并可能降低总医疗费用的策略。

局限性

  • 研究未设盲,部分结局依赖参与者报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adherence to medicines is low for a variety of reasons, including the cost borne by patients. Some jurisdictions publicly fund medicines for the general population, but many jurisdictions do not, and such policies are contentious. To our knowledge, no trials studying free access to a wide range of medicines have been conducted. METHODS AND FINDINGS: We randomly assigned 786 primary care patients who reported not taking medicines due to cost between June 1, 2016 and April 28, 2017 to either free distribution of essential medicines (n = 395) or to usual medicine access (n = 391). The trial was conducted in Ontario, Canada, where hospital care and physician services are publicly funded for the general population but medicines are not. The trial population was mostly female (56%), younger than 65 years (83%), white (66%), and had a low income from wages as the primary source (56%). The primary outcome was medicine adherence after 2 years. Secondary outcomes included control of diabetes, blood pressure, and low-density lipoprotein (LDL) cholesterol in patients taking relevant treatments and healthcare costs over 2 years. Adherence to all appropriate prescribed medicines was 38.7% in the free distribution group and 28.6% in the usual access group after 2 years (absolute difference 10.1%; 95% confidence interval (CI) 3.3 to 16.9, p = 0.004). There were no statistically significant differences in control of diabetes (hemoglobin A1c 0.27; 95% CI -0.25 to 0.79, p = 0.302), systolic blood pressure (-3.9; 95% CI -9.9 to 2.2, p = 0.210), or LDL cholesterol (0.26; 95% CI -0.08 to 0.60, p = 0.130) based on available data. Total healthcare costs over 2 years were lower with free distribution (difference in median CAN$1,117; 95% CI CAN$445 to CAN$1,778, p = 0.006). In the free distribution group, 51 participants experienced a serious adverse event, while 68 participants in the usual access group experienced a serious adverse event (p = 0.091). Participants were not blinded, and some outcomes depended on participant reports. CONCLUSIONS: In this study, we observed that free distribution of essential medicines to patients with cost-related nonadherence substantially increased adherence, did not affect surrogate health outcomes, and reduced total healthcare costs over 2 years. TRIAL REGISTRATION: ClinicalTrials.gov NCT02744963.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Persaud N, Bedard M, Boozary A, et al. Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial. PLoS Med. 2021. PMID: 34019540. doi:10.1371/journal.pmed.1003590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。